Diabetes and vascular disease: A new international trial

Asian Cardiovascular and Thoracic Annals

Volumn 11, Issue 2, 2003, Pages 180-184

  Patel, Anushka ^a   Chalmers, John ^a   Chaturvedi, Vivek ^a   Currie, Rochelle ^a   Monaghan, Helen ^a   Neal, Bruce ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDAPAMIDE; INSULIN; PERINDOPRIL; PERINDOPRIL PLUS INDAPAMIDE; PLACEBO; PRETERAX; SULFONYLUREA; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG EFFECT; GLUCAGON BLOOD LEVEL; HEALTH CARE COST; HEART INFARCTION; HUMAN; HYPERTENSION; INCOME; LONG TERM CARE; LOWEST INCOME GROUP; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW; RISK FACTOR; SOCIOECONOMICS; VASCULAR DISEASE;

EID: 0141483618     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230301100224     Document Type: Review

References (20)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
2. Wang ZZ, Huang XZ, Tang SB, Chen YM, Chen LG, Jin ZX, et al. The prevalence of NIDDM and IGT and related factors among residents in some areas of Hubei Province, China. Biomed Environ Sci 2000;13:148-53.
3. Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R. Intra-urban differences in the prevalence of the metabolic syndrome in southern India - The Chennai Urban Population Study (CUPS No. 4). Diabet Med 2001;18:280-7.
4. Sutanegara D, Budhiarta AA. The epidemiology and management of diabetes mellitus in Indonesia. Diabetes Res Clin Pract 2000;50(Suppl 2):9-16.
5. Mafauzy M, Mokhtar N, Mohamad WB, Musalmah M. Diabetes mellitus and associated cardiovascular risk factors in north-east Malaysia. Asia Pac J Public Health 1999;11:16-9.
6. Lee WR. The changing demography of diabetes mellitus in Singapore. Diabetes Res Clin Pract 2000;50(Suppl 2):35-9.
7. Puavilai G, Kheesukapan P, Chanprasertyotin S, Chantraraprasert S, Suwanvilaikorn S, Nitiyanant W, et al. Random capillary plasma glucose measurement in the screening of diabetes mellitus in high-risk subjects in Thailand. Diabetes Res Clin Pract 2001;51:125-31.
8. Chen KT, Chen CJ, Gregg EW, Engelgau MM, Narayan KM. Prevalence of type 2 diabetes mellitus in Taiwan: Ethnic variation and risk factors. Diabetes Res Clin Pract 2001;51:59-66.
9. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-68.
10. Asia Pacific Cohort Studies Collaboration. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 2003;26:360-66.
11. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998;21:296-309.
12. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ 2000;321:412-9.
13. Lièvre M, Gueyffier F, Ekbom T, Fagard R, Cutler J, Schron E, et al.; INDANA Steering Committee. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. Diabetes Care 2000;23(Suppl 2):B65-71.
14. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, et al.; Systolic Hypertension in Europe Trial Investigators. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999;340:677-84.
15. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.
16. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Lancet 2000;356:1955-64.
17. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.
18. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-12.
19. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
20. ADVANCE Management Committee. Study rationale and design of ADVANCE: Action in Diabetes and Vascular Disease - Preterax and Diamicron MR Controlled Evaluation. Diabetologia 2001;44:1118-20.